Literature DB >> 7608461

Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion.

J Cheirif1, J B Narkiewicz-Jodko, H K Hawkins, J S Bravenec, M A Quinones, J K Mickelson.   

Abstract

OBJECTIVES: This study sought to determine whether myocardial contrast echocardiography could be used to detect and quantitate collateral blood flow capable of limiting the effects of ischemia in an experimental model of coronary thrombosis and reperfusion.
BACKGROUND: Myocardial contrast echocardiography has been used to assess collateral blood flow in humans, but this technique has not been extensively validated in the experimental laboratory.
METHODS: Myocardial ischemia occurred after electrically induced left circumflex coronary artery thrombosis in a canine model. Ischemia was intensified by administration of vasodilators. Reperfusion was induced with recombinant tissue-type plasminogen activator. Myocardial perfusion was assessed with contrast echocardiography and radiolabeled microspheres. Infarct size was determined by histochemical staining methods. Myocardial samples were evaluated histologically.
RESULTS: The dogs were classified into two groups on the basis of contrast echocardiographic detection of perfusion in the ischemic region: those with (n = 13) and without collateral flow (n = 10). Collateral perfusion detected by contrast echocardiography paralleled changes detected by radiolabeled microspheres during thrombosis and vasodilator administration. A 91% agreement was observed between the two techniques in detecting collateral flow > 0.3 ml/min per g (p < 0.0001). Collateral perfusion correlated directly with radial shortening fractions of the ischemic myocardium (p < 0.01). Recovery of function after reperfusion was faster, infarct size was smaller (mean [+/- SD] 4 +/- 1% vs. 11 +/- 3%, p = 0.05), and histopathologic injury was less in dogs with than without collateral flow, respectively (p < 0.05).
CONCLUSIONS: Myocardial contrast echocardiography can identify physiologically significant collateral vessels capable of limiting the degree of ischemic damage during coronary thrombosis. The magnitude of collateral flow and the change in flow induced by vasodilators can be assessed and compares favorably with the microsphere standard.

Entities:  

Mesh:

Year:  1995        PMID: 7608461     DOI: 10.1016/0735-1097(95)80034-e

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Added value of contrast echocardiography in assessing myocardial viability.

Authors:  A Nagy; F L Dini; D Rovai
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Contrast echocardiography 1996. A review.

Authors:  H R Villarraga; D A Foley; S L Mulvagh
Journal:  Tex Heart Inst J       Date:  1996

3.  Quantitative contrast echocardiographic assessment of collateral derived myocardial perfusion during elective coronary angioplasty.

Authors:  S F de Marchi; M Schwerzmann; M Fleisch; M Billinger; B Meier; C Seiler
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 4.  Coronary microembolization--its role in acute coronary syndromes and interventions.

Authors:  R Erbel; G Heusch
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

5.  Collateral Circulation in Chronic Total Occlusions – an interventional perspective

Authors:  Gim-Hooi Choo
Journal:  Curr Cardiol Rev       Date:  2015-11-06

Review 6.  Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary collateral circulation and atherosclerotic plaque.

Authors:  Giorgio Baroldi; Riccardo Bigi; Lauro Cortigiani
Journal:  Cardiovasc Ultrasound       Date:  2005-03-01       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.